Selected article for: "airway inflammation and cytokine production"

Author: Murdaca, Giuseppe; Tonacci, Alessandro; Negrini, Simone; Greco, Monica; Borro, Matteo; Puppo, Francesco; Gangemi, Sebastiano
Title: Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models
  • Document date: 2019_8_13
  • ID: 1rmwwjgi_15
    Snippet: Six studies were published on animal models, of which three investigated asthma, and one each COPD, airway disease, and airway hyper-responsiveness. All those studies took into account mice models, with miR-21 that was investigated in three out of the six works. Overall, the results were encouraging, with minor differences. Indeed, as observed by Collison et al. [24] , just the inhibition of miR-145, but not miR-21 or let-7b, inhibited eosinophil.....
    Document: Six studies were published on animal models, of which three investigated asthma, and one each COPD, airway disease, and airway hyper-responsiveness. All those studies took into account mice models, with miR-21 that was investigated in three out of the six works. Overall, the results were encouraging, with minor differences. Indeed, as observed by Collison et al. [24] , just the inhibition of miR-145, but not miR-21 or let-7b, inhibited eosinophilic inflammation, mucus hypersecretion, TH2 cytokine production, and airway hyper-responsiveness, and also Plank et al. [30] on asthma observed that the use of the respective antagomiR (anti-miR-155-5p) reduced miR-155-5p expression, but failed to alter the disease phenotype.

    Search related documents:
    Co phrase search for related documents
    • airway disease and cytokine production: 1, 2, 3, 4, 5
    • airway disease and disease phenotype: 1, 2, 3, 4, 5
    • airway disease and eosinophilic inflammation: 1
    • airway disease and hyper responsiveness: 1, 2, 3, 4, 5
    • airway disease and mice model: 1, 2, 3
    • airway disease and mucus hypersecretion: 1, 2, 3, 4
    • airway hyper responsiveness airway disease and hyper responsiveness: 1, 2
    • airway hyper responsiveness and hyper responsiveness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • animal model and cytokine production: 1, 2, 3, 4
    • animal model and disease phenotype: 1, 2, 3, 4
    • animal model and hyper responsiveness: 1
    • animal model and mice model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cytokine production and disease phenotype: 1, 2, 3, 4
    • cytokine production and eosinophilic inflammation: 1, 2
    • cytokine production and hyper responsiveness: 1, 2
    • cytokine production and mice model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • cytokine production and mucus hypersecretion: 1, 2
    • cytokine production and work investigate: 1, 2, 3
    • disease phenotype and mice model: 1, 2